India Pharmaceutical Regulatory Report 2013

The India Pharmaceutical Regulatory Report comprehensively covers all aspects of India pharmaceutical regulations. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2012. As India’s pharmaceutical market is poised for steady growth, reaching an estimated $13 billion, understanding of Indian regulatory issues is crucial for success.

Updates for 2013 include:

First compulsory license granted by the Indian Patent Office and its implication for the pharmaceutical industry
New CDSCO regulations concerning biosimilars and ethics committees
New CDSCO guidelines on compensating for injuries and deaths during clinical trials

To download this report, please click on India Pharmaceutical Regulatory Report 2013

Overview of India’s Economy
Overview of India’s Healthcare System
1. India’s Healthcare System: Goals and Challenges
2. Healthcare Providers
3. Healthcare Spending
4. Conclusion
India’s Pharmaceutical Industry
1. Market Profile
2. Industry Profile
3. Conclusion
India Pharmaceutical Regulations Overview
1. Governing Legislation
2. Agencies
Drug Registration and Import
1. Overview
2. New Drug Registration
3. Import Registration
4. Import License
5. Adverse Event Reporting
Manufacturing
1. Overview
2. Licensing
3. Good Manufacturing Practice
Distribution
1. Overview
2. Licensing
3. Record-Keeping
4. Packaging and Labeling
5. Price Controls
6. Prescription Management
Clinical Trials and R&D
1. Overview
2. Restrictions on Clinical Trials
3. Global Clinical Trials
4. Licensing and Monitoring
5. Good Laboratory Practice
6. Accreditation of Testing Laboratories
Intellectual Property Protection
1. History
2. Patent Applications
3. Remaining Restrictions
4. Prosecution of IP Violations
Drug Advertising
Conclusion

Table of Contents